The possible explanation may be that NF-κB is a well-known downstream of Akt in cancer [28, 29], and NF-κB can directly bind to IL-6 promoter and subsequently activate IL-6 gene expression [30, 31]. The gene discussed is NFKB1; the disease is cancer.